Document:

EXHIBIT 10.2 - DECLARATION RELATING TO GOVERNMENT COMMISSION'S GERMAN CORPORATE
GOVERNANCE CODE

     The Board of Managing Directors and Supervisory Board of Deutsche Bank AG
state in accordance with {section} 161 German Stock Corporation Act (AktG):

     Deutsche Bank AG complies with the recommendations of the "Government
Commission's German Corporate Governance Code" with the following exceptions:

     For the members of the Board of Managing Directors and Supervisory Board,
there is a directors and officers' liability insurance policy with only a small
deductible (Code No. 3.8).  This is actually a group insurance policy for a
large number of staff members in Germany and abroad.  Internationally, a higher
deductible is not customary.  It is not considered appropriate to differentiate
between board members and staff members.

     Separate compensation is not currently paid for chairing Supervisory Board
committees.  At the next General Meeting, the Board of Managing Directors and
Supervisory Board will propose amending {section} 14 (1) of the Articles of
Association of Deutsche Bank AG to provide for compensation for chairing
Supervisory Board committees (Code No. 5.4.5 (1), sentence 3).EXHIBIT 10.3 - WRITTEN STATEMENTS REQUIRED BY 18 U.S.C SECTION 1350

                     CHIEF EXECUTIVE OFFICER CERTIFICATION
                      PURSUANT TO 18 U.S.C. SECTION 1350

      The  undersigned hereby certifies that to his knowledge the Annual Report
on  Form  20-F   for  the  year  ended  December  31,  2002  of  Deutsche  Bank
Aktiengesellschaft  fully  complies  with  the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934  and that information contained in
such report fairly presents, in all material respects,  the financial condition
and results of operations of Deutsche Bank Aktiengesellschaft.

Date:  March 27, 2003
                                      /s/ DR. JOSEF ACKERMANN
                                      Dr. Josef Ackermann
                                      Spokesman  of  the  Board   of   Managing
                                      Directors

A  signed  original  of  this  written statement required by Section 906 of the
Sarbanes-Oxley  Act of 2002 (18 U.S.C.  Section  1350)  has  been  provided  to
Deutsche  Bank  Aktiengesellschaft  and  will  be  retained  by  Deutsche  Bank
Aktiengesellschaft  and  furnished to the Securities and Exchange Commission or
its staff upon request.

<PAGE>
                     CHIEF FINANCIAL OFFICER CERTIFICATION
                      PURSUANT TO 18 U.S.C. SECTION 1350

      The undersigned hereby  certifies that to his knowledge the Annual Report
on  Form  20-F  for  the  year  ended   December  31,  2002  of  Deutsche  Bank
Aktiengesellschaft fully complies with the  requirements  of  section  13(a) or
15(d) of the Securities Exchange Act of 1934 and that information contained  in
such  report fairly presents, in all material respects, the financial condition
and results of operations of Deutsche Bank Aktiengesellschaft.

Date:  March 27, 2003
                                      /s/ DR. CLEMENS BOERSIG
                                      Dr. Clemens Boersig
                                      Member of the Board of Managing Directors
                                      Chief Financial Officer

A signed  original  of  this  written  statement required by Section 906 of the
Sarbanes-Oxley  Act  of 2002 (18 U.S.C. Section  1350)  has  been  provided  to
Deutsche  Bank  Aktiengesellschaft  and  will  be  retained  by  Deutsche  Bank
Aktiengesellschaft  and  furnished to the Securities and Exchange Commission or
its staff upon request.<PAGE>
                                                                   EXHIBIT 10.12

                     AMENDMENT TO 1992 DIRECTOR OPTION PLAN

                       (APPROVED BY THE BOARD OF DIRECTORS
                                       ON
                                  MAY 14, 2002)

      RESOLVED, that Section 2(i) of the PharmChem Laboratories, Inc. 1992
Director Option Plan is hereby amended and restated as follows:

            (i) "Fair Market Value" means, as of any date, the value of a share
      of Common Stock determined as follows:

            (i) if the Common Stock is listed on any established stock exchange
      or a national market system, including, without limitation, The Nasdaq
      National Market or The Nasdaq Small Cap Market of The Nasdaq Stock Market,
      its Fair Market Value shall be the closing sales price for such stock (or
      the closing bid, if no sales were reported) as quoted on such exchange or
      system for the last market trading day prior to the time of determination,
      as reported in The Wall Street Journal or such other source as the
      Committee deems reliable; or

            (ii) in the absence of an established market for the Common Stock,
      the Fair Market Value thereof shall be determined in good faith by the
      Board.

                                            /s/ David A. Lattanzio
                                            ---------------------------------
                                            David A. Lattanzio
                                            Secretary of the Meeting<PAGE>
                                                                   EXHIBIT 10.16

                     AMENDMENT TO 1997 EQUITY INCENTIVE PLAN

                       (APPROVED BY THE BOARD OF DIRECTORS
                                       ON
                                  MAY 14,2002)

      RESOLVED, that Section 2(m) of the PharmChem Laboratories, Inc. 1997
Equity Incentive Plan is hereby amended and restated as follows:

            (m) "Fair Market Value" of a Share means, as of any date, the value
      of a share of Common Stock determined as follows:

            (i) if the Common Stock listed on any established stock exchange or
      a national market system, including, without limitation, The Nasdaq
      National Market or The Nasdaq Small Cap Market of The Nasdaq Stock Market,
      its Fair Market Value shall be the closing sales price for such stock (or
      the closing bid, if no sales were reported) as quoted on such exchange or
      system for the last market trading day prior to the time of determination,
      as reported in The Wall Street Journal or such other source as the
      Committee deems reliable; or

            (ii) in the absence of an established market for the Common Stock,
      the Fair Market Value thereof shall be determined in good faith by the
      Committee.

                                              /s/ David A. Lattanzio
                                              ---------------------------------
                                              David A. Lattanzio
                                              Secretary of the Meetingexv10w94

 

Exhibit 10.94

March 3, 2003

     RE: Separation Agreement and Release

Dear Rod:

As we have discussed, Aspect is offering this separation package in recognition
of your many contributions. This letter sets forth the terms and conditions of
your separation agreement and the parties mutual release of the other from any
liability. Please know that acceptance or rejection of this agreement will in
no way affect Aspect’s obligation to pay your accrued salary through the
Resignation Date, including all unused accrued benefits, subject to the
standard payroll deductions and withholdings.

	 	1.	 	Responsibilities. Your last day of employment for Aspect will be
March 7, 2003 (the “Resignation Date”). After the Resignation Date you
agree to provide Aspect with services as an independent consultant until
the earlier of February 20, 2004 or the date upon which you accept other
full-time employment (the “Separation Date”). Until the Separation Date,
you agree to transition your duties as President of Worldwide Market
Development, Marketing and Alliances and remain reasonably available from
time to time to advise and assist the senior executives of Aspect. You
acknowledge that your services will be performed as an independent
contractor, not as an employee, and that you will not be eligible or
entitled to participate in any Aspect benefit or incentive program.
	 
	 	2.	 	Payments. In return for your services after the Resignation Date and
your release of Aspect from any liability, Aspect will pay you an amount
equal to a total of nine (9) months base salary, which is equal to two
hundred and fifty-three thousand one hundred and twenty-five dollars
($253,125), and transfer title to the Aspect personal computer and
cellular phone in your possession (the “Settlement”).
	 
	 	3.	 	Schedule of Settlement Payments. Aspect will pay the Settlement in the
following manner: i) for the first six (6) months after the Resignation
Date $12,980.77 bi-weekly less all applicable tax withholding; and ii)
following the first six (6) months up to the Separation Date, $6490.39
bi-weekly less all applicable tax withholdings.
	 
	 	4.	 	Other Employment. In the event that you accept full-time employment
with another employer, Aspect will pay you the outstanding remainder of
the Settlement in a lump sum. However, if you accept employment with a
competitor of Aspect, then it is agreed that Aspect will have no
obligation to pay any further installment of the Settlement and no
further obligation to pay any COBRA premium for your health benefits. It
is understood that a competitor of Aspect will be considered exclusively
these companies: Cisco, Genesys/Alcatel, Avaya, IEX, Blue Pumpkin,
Siemens, Nortel, and Rockwell.
	 
	 	5.	 	Benefits. Aspect will agree to pay the cost of your COBRA health
benefits through the Separation Date. After the Separation Date, you may
continue coverage for the remainder of the COBRA period by paying the
full premium cost plus a small administrative fee.
	 
	 	6.	 	Stock Options. Effective on the Resignation Date, you will receive the
equivalent of one year of accelerated stock option vesting on all
outstanding options. All unvested stock options will be cancelled upon
the Resignation Date. For each fully vested stock option as of the
Resignation Date, you will receive an extended period of time to exercise
these stock options. Each fully vested stock option will remain
exercisable until February 20, 2004.
	 
	 	7.	 	Outplacement. For outplacement services prior to the Separation Date,
Aspect will agree to pay Lee Hecht Harrison for up to $7,500 in
outplacement services.
	 
	 	8.	 	Expense Reimbursements. You agree that, within ten (10) days of the
Resignation Date, you will submit your final expense reimbursement
statement reflecting all business expenses for which you seek
reimbursement. Aspect will reimburse you for those expenses authorized
under Aspect’s reimbursement policies.
	 
	 	9.	 	Return of Company Property. By the Resignation Date, you agree to
return to Aspect all documents and other Aspect property that you have
had in your possession at any time, including, but not limited to, Aspect
files, notes, drawings, records, business plans and forecasts, financial
information, specifications, computer-recorded
information, tangible property including, but not limited to, credit cards,
entry cards, identification badges and keys; and, any materials of any kind
that contain or embody any proprietary or confidential information of
Aspect.
	 
	 	10.	 	Proprietary Information Obligations. You acknowledge your continuing
obligations under your Proprietary Information and Inventions Agreement
not to use or disclose any confidential or proprietary information of
Aspect.
	 
	 	11.	 	Non-disparagement. Both you and Aspect agree not to disparage the
other party, and the other party’s officers, directors, employees,
shareholders and agents.
	 
	 	12.	 	Non-solicitation. You agree that for one (1) year following the
Separation Date, you will not directly or indirectly solicit any
employee, consultant, or independent contractor of Aspect to terminate
his or her relationship with Aspect.
	 
	 	13.	 	Cooperation in Legal Proceedings. You will agree to provide reasonable
cooperation in connection with any action or proceeding which relates to
Aspect, including without limitation, any litigation or dispute arising
out of actions or inactions of the company of which you have knowledge or
information. You further agree to cooperate with the company in supplying
data, information, and expertise within your special knowledge or
competence and otherwise assist the company in the protection of the
interests of the company and its affiliates. Aspect will reimburse you
any expenses reasonably incurred in connection with such cooperation.
	 

 

 

	 	14.	 	Release of All Legal Claims. In consideration for the payments and
promises described above, you will agree to completely release and
forever discharge Aspect from all claims, rights, obligations, and causes
of action of any and every kind, known or unknown, which you may now
have, or ever had, in any way connected with the employment relationship
with Aspect, which includes any actions during that relationship or the
termination of that relationship. Your release includes but is not
limited to: a) all “wrongful discharge” or “wrongful termination” claims;
b) all claims relating to any contracts of employment, express or
implied; c) all claims for breach of any covenant of good faith and fair
dealing, express or implied; d) all claims for any tort of any nature; e)
all claims for attorney’s fees and costs; and f) all claims under any
federal, state, or municipal statute, ordinance, regulation or
constitution, including specifically any claims under the California Fair
Employment and Housing Act, the California Labor Code, Title VII of the
Civil Rights Act of 1964, the Americans With Disabilities Act, the
Employee Retirement Income Security Act, the Age Discrimination in
Employment Act of 1967 (“ADEA”), the Older Workers Benefit Protection
Act, and any other laws or regulations relating to employment or
employment discrimination.
	 
	 	15.	 	Acceptance. You will have twenty-one (21) days from the date of this
letter to consider whether to release possible claims in exchange for the
payments and promises described above. This period is intended to
provide you with time to consider the release, and to consult with a
trusted advisor, accountant, or attorney before making your decision.
Because your acceptance of the settlement and release of claims is an
important act, you should consider it carefully. If you decide to accept
the terms and conditions described in this letter, you will have seven
days to change your mind and revoke your decision. You may do so by
providing written notice to Aspect.
	 
	 	16.	 	Acknowledgment of California Civil Code § 1542: You acknowledge that
you have read Section 1542 of the Civil Code of the State of California,
which provides:

		
	 	A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES
NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE
RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS
SETTLEMENT WITH THE DEBTOR.

     You understand that you voluntarily waive the rights under Section 1542
and assume the risk of any claim that exists as of the date you accept this
agreement, but of which you are unaware, and which if you knew, would
materially affect your decision.

	 	17.	 	Aspect’s Release. Aspect will agree to completely release and forever
discharge you from all claims, rights, obligations, and causes of action
of any and every kind, known or unknown, which it may now have, or ever
had, in any way connected with your employment relationship with Aspect,
and Aspect voluntarily waives the rights under Section 1542 of the
California Civil Code.
	 
	 	18.	 	Entire Agreement. This terms set forth in this letter will constitute
the entire understanding of the parties regarding your resignation and
separation from Aspect. This agreement will be interpreted under
California law, and the parties agree that any action to enforce the
terms of this agreement will be submitted exclusively to the state or
federal courts of Santa Clara County. You warrant that: a) you have read
and understood all of the terms in this document; b) that you have had
the opportunity to consult with legal counsel of your own choosing and to
have the terms fully explained to you; and c) that you are not executing
this agreement in reliance on any promises, representations or
inducements other than those contained in this document.

     If you accept these terms, please sign below and return the original to me. I
wish you good luck in your future endeavors.

	 	 	 	 
	
Sincerely,
	 
	 	 	 	 
	
ASPECT COMMUNICATIONS CORPORATION	 
	 	 	 	 
	 	 	 	 
	
By:	 	 	 
	 	 	

	 
	 	 	
John R. Viera                                                  Date	 
	 	 	
Sr. Vice President, Human Resources	 

I elect to receive the payments and benefits under the terms set forth above.
I understand and agree that by this election that I am waiving any and all
claims that I may have against Aspect.

AGREED:

	 	 
	
	 
	Rod Butters

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}]]